Fred S. Zeidman - 14 Mar 2026 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)

Reporting relationship: Director
Issuer ticker: BJDX
Reported as of: 14 Mar 2026
Net transaction value: +$25,000
SEC form: 4
Accepted by SEC: 18 May 2026, 17:19:30 UTC
Prior SEC filing: 25 Jun 2024
Next SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Fred S Zeidman

Key filing fact

Fred S. Zeidman filed Form 4 for Bluejay Diagnostics, Inc. (BJDX) on 18 May 2026.

Key facts

This page summarizes Fred S. Zeidman's Form 4 filing for Bluejay Diagnostics, Inc. (BJDX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 May 2026, 17:19.

Change

Previous filing in this sequence was filed on 25 Jun 2024.
Current net transaction value: +$25,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000927704 Primary reporting owner

ZEIDMAN FRED S

Relationship: Director
Address: C/O BLUEJAY DIAGNOSTICS, INC., 360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Signature: /s/ Fred S Zeidman
Signature date: 18 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BJDX transaction

Common Stock

Purchase

Transaction value: $25,000
Shares: +12,500
Change %
Price: $2.00
Shares after: 12,500
Date: 14 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 14, 2026, Mr. Zeidman purchased 12,500 shares of the issuer's common stock from the issuer in a private placement at a price of $2.00 per share.